Facebook
X
LinkedIn
Forward
2025 AAEM Annual Conference
Activity Overview
If you were not able to attend the 2025 AAEM Annual Conference in person, you can view on demand! The theme this year was "Everyday Exposures and What to Do." From chemicals affecting our hormones and epigenetic predispositions increasing inflammation to showing how exposures to toxins like mold, endotoxins, and neoantigens affect overall health, this year's conference has so much to offer. This conference and the amazing presenters will teach you what Environmental Medicine is all about and how incorporating the evidence-based, real-world treatments, you can change the way you practice and improve outcomes.
Target Audience
This activity is designed for an audience of Physicians, Nurse Practitioners, Physician Associates, as well as any other healthcare professionals interested in Environmental Medicine.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
Demystifying Endotoxin: Targeting microbial lipopolysaccharides to quench the fire within - Tom O’Bryan DC
- Identifying the relationship between microbiome health and LPS
From Puberty to Menopause: Mitigating Effects of Endocrine Disruptors Across the Lifespan to Decrease Incidence of Disease - Nicole Salezke NP
- Identifying Patterns of Endocrine Disruption and their Impacts on Hormonal Pathways
Toxicity and Testosterone Deficiency in Young Men - Ty Vincent MD
- Interpret testosterone levels in the context of optimal quality of life and performance.
Every Breath You Take: Air Pollution and Metabolomics - Betsy Redmond Ph.D, MMSc, RDN
- Identify how particulate matter exposure can lead to changes in gut bacterial patterns.
Intersections of MCAS, Hypercoagulability, and Biofilms - Kelly McCann MD
- Discuss the fundamentals of hypercoagulability: symptoms, testing, and treatment.
The Biological Impacts of Polarized Waveforms - Peter Sullivan MS
- Identify how polarized waveforms can contribute to over-excitation and sympathetic nervous system overload.
Silent Threats: The Top 8 Environmental Pollutants Driving Neurodegeneration- Sources, Prevention and Healing - Medeya Tsnobiladze ND
- Outline integrative treatment approaches to mitigate the impact of pollutants on brain health.
The Role of Neoantigens in Autoimmunity - Aristo Vojani PhD
- Describe how antibodies can help to identify the triggers so that they may be removed, preventing the progression into possible autoimmune disease.
Phospholipid Therapy in Environmental Medicine: Healing Membranes, Removing Toxins and Reversing the Cell Danger Response - Werner Vosloo ND
- Outline the structural changes to cell plasma and intracellular organelle membranes in chronic environmental and infectious illness.
Restoring Homeostasis through Biomagnetism: A New Frontier in Environmental Medicine - Luis Garcia MD
- Explain that complex illnesses often stem from multiple pathogens interacting, emphasizing the need for a comprehensive approach to achieve effective recovery.
Inflammageing From Environmental and Genetic Factors - Bob Miller BCTN, ANWPB
- Identify the environmental factors that stimulate NLRP3 and create Inflammageing and other stimulators and inhibitors of NLRP3
Assessing the Distribution of Per- and Polyfluoroalkyl Substances (PFAS) in Air Particulate Matter and Associated Inhalation Health Risks - Natalia Soares Quinete
- Assess health risks associated with PFAS inhalation
Pesticides: Insidious Everyday Exposures - Lyn Patrick ND
- Identify the disease risks associated with pyrethroid pesticides
How Neural Therapy and Blockage-Based Care can Transform Your Practice - Richard Nahas MD
- Discuss the hypothesis that interference fields are common, treatable lesions in the body that are unknown to modern medicine.
Neurotoxic outcomes of mold toxicity - Raymond Singer PhD
- Analyze specific neuropsychological outcomes common to mold neurotoxicity
Today's Regulatory Updated Facing Advanced Medicine Healthcare Practitioners - Jaques Simon Esq
- State the law which governs your practice
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Faculty / Planners DISCLOSURES | ||
Name | Relationship | Commercial Interest |
Luis Garcia, BS (faculty) | Ownership Interest | DrG Biomagnetism |
Kelly McCann, MD (faculty) | N/A | Nothing to disclose |
Bob Miller, BCTN, ANWPB (faculty) | Ownership Interest / Researcher | Functional Genomics Analysis
|
Richard Nahas, MD (faculty) | N/A | Nothing to disclose |
Tom O’Bryan, DC (faculty) | Consultant | Vibrant Wellness |
Lyn Patrick, ND (faculty) | Ownership Interest | EMEI |
Betsy Redmond, Ph.D, MMSc, RDN (faculty) | Consultant | Diagnostic Solutions Laboratory |
Nicole Saleske, FNP, APNP (faculty) | N/A | Nothing to disclose |
Jaques Simon, Esq (faculty) | N/A | Nothing to disclose |
Raymond Singer, PhD. (faculty) | N/A | Nothing to disclose |
Natalia Soares-Quinete, PhD. (faculty) | N/A | Nothing to disclose |
Peter Sullivan, MS (faculty) | N/A | Nothing to disclose |
Medeya Tsnobiladze, ND (faculty) | N/A | Nothing to disclose |
Ty Vincent, MD (faculty) | N/A | Nothing to disclose |
Aristo Vojdani, PhD, MSC (faculty) | Ownership Interest | Immunosciences |
Werner Vosloo, ND (faculty) | Ownership Interest | Return Healthy |
Dorothy Caputo, MA, BSN, RN – President, AKH Inc., Advancing Knowledge in Healthcare | N/A | Nothing to disclose |
Bernadette Marie Makar, MSN, NP-C, APRN-C- BC- Nurse Planner (planner/reviewer) | N/A | Nothing to disclose |
Dorothy Duffy, RPH (planner/reviewer) | N/A | Nothing to disclose |
AKH Inc Staff and Planners | N/A | Nothing to disclose |
AAEM Staff and Planners | N/A | Nothing to disclose |
All of the relevant financial relationships listed for these individuals have been mitigated. | ||
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American Academy of Environmental Medicine (AAEM). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 13.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 13.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For physicians, hours of participation are the number of AMA PRA Category 1 Credits™ awarded.
Nurses
Credit being awarded: 13.5 ANCC contact hours
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare, designates this continuing education activity for 13.5 contact hours.
AAPA Credit Designation Statement
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and American Academy of Environmental Medicine (AAEF). AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 13.5 contact hour(s) (which includes 8.0 hour(s) of pharmacology)
Available Credit
- 13.50 AANP
- 13.50 AAPA Category 1 CME
- 13.50 ACPE Pharmacist
- 13.50 ACPE Pharmacy Technician
- 13.50 AMA PRA Category 1 Credit™
- 13.50 ANCC
- 13.50 Attendance